Advent Technologies Holdings Inc
NASDAQ:ADN

Watchlist Manager
Advent Technologies Holdings Inc Logo
Advent Technologies Holdings Inc
NASDAQ:ADN
Watchlist
Price: 0.42 USD 2.41% Market Closed
Market Cap: $1.6m

Advent Technologies Holdings Inc
Investor Relations

Advent Technologies Holdings, Inc. operates as an advanced materials and technology development company. The company is headquartered in Boston, Massachusetts and currently employs 200 full-time employees. The company went IPO on 2018-11-16. The firm develops, manufactures, and assembles complete fuel cell systems and the critical components that determine the performance of hydrogen fuel cells and other energy systems. Its product offerings include full fuel cell systems and the membrane electrode assembly (MEA) at the center of the fuel cell. The company is a provider of fuel cell systems, high-temperature proton exchange membranes (HT-PEMs), fuel cells, and HT-PEM-based MEAs, which are critical components used in fuel cells, and other electrochemical applications such as electrolyzers and flow batteries. The company also develops and manufactures MEAs, and designs fuel cell stacks and complete fuel cell systems for a range of customers in the stationary power, portable power, automotive, aviation, energy storage and sensor markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2023
Call Date
Aug 20, 2024
AI Summary
Q4 2023

Revenue Decline: Advent reported Q4 revenue of $1.5 million, down from $2 million a year ago, mainly due to lower orders for stationary fuel cell systems.

Cost Reduction: The company completed major restructuring, cutting costs by 70% and closing non-core facilities, with total costs expected below $20 million in 2024 versus $50 million in 2023.

Strategic Refocus: Advent is shifting its business model to focus on MEA innovation, intellectual property, and manufacturing scale, moving away from end-product manufacturing.

No 2024 Revenue Guidance: Due to market uncertainties and a new focus on strategic partnerships, Advent is not providing revenue guidance for 2024.

Liquidity Concerns: Existing cash and projected cash flows are not enough to support operations for the next 12 months; Advent is exploring options to raise additional capital.

Key Partnerships: The company highlighted ongoing collaborations with Airbus, Hyundai, the U.S. Army, and other major OEMs, targeting commercial scale-up plans in 2026 and beyond.

Path to Profitability: Management aims for EBITDA-positive operations by 2025 through a lean structure and strategic technology licensing.

Key Financials
Revenue
$1.5 million
R&D Expenses
$4 million
Administrative and Selling Expenses
$6.7 million
Total Operating Expenses
$10.7 million
Net Loss
$25.7 million
Net Loss Per Share
$12.04
Adjusted Net Loss
$22.1 million
Adjusted Net Loss Per Share
$10.32
Restricted Cash Reserves
$3.6 million
Total Costs (Expected 2024)
below $20 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. James F. Coffey J.D.
COO, General Counsel & Corporate Secretary
No Bio Available
Dr. Emory Sayre De Castro Ph.D.
CTO & Executive Director
No Bio Available
Dr. Panoraia Gourdoupi Ph.D.
Senior Vice President of Corporate Business Development - Advent Technologies SA
No Bio Available
Mr. Gary L. Herman
Interim CEO & Director
No Bio Available
Mr. Morten Hougaard Sorensen
Senior Vice President
No Bio Available
Dr. Steven Rock
Chief Strategy Officer
No Bio Available
Mr. George Paloumpis
Chief of Operations of Patras
No Bio Available

Contacts

Address
MASSACHUSETTS
Boston
200 Clarendon Street, 119 Mt Auburn Street, Suite 400
Contacts
+18572647035.0
amciacquisition.com